Susan Hasty, Publisher
Table of Contents . . . June 5th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Oncology Business Week | Other Publications
Antisoma - Cancer drug developer drops AS1405 to accelerate AS1411
Avecia - Manufacturing agreement signed for ProMune
Celator Pharmaceuticals, Inc. - Biopharmaceutical firm closes $40M financing
Cell Genesys, Inc. - Synergistic antitumor activity reported for GVAX cancer vaccine
Conforma Therapeutics Corp. - Cancer therapeutics company completes final tranche of financing
Curis, Inc. - FDA accepts Genentech's application to start skin cancer treatment phase I trial
EntreMed, Inc. - Panzem maker reports Q1 net loss of $5.5 million
Exelixis, Inc. - Company files IND application for anticancer compound XL844
Genzyme Corporation - Hospital and cancer institute grant rights to develop diagnostic test
Immunicon Corporation - Diagnostics company reports loss of $0.30 per share
Incyte Corporation - Oncology drug maker reports loss of $0.24 per share
McMaster University - New prostate cancer studies look at hormone and protein connection
Miikana Therapeutics, Inc. - Biopharmaceutical company licenses phase II clinical anticancer compound
Novartis Oncology - New drug applications filed for treatment of blood transfusions iron overload
Onyx Pharmaceuticals, Inc. - All patients in phase III trial offered sorafenib for renal cell carcinoma
Academy Sinica, Taipei - Different techniques used for urinary protein analysis of lung cancer patients
Adventrx Pharmaceuticals, Inc. - Preliminary results for CoFactor phase II trial published
Agilent Technologies, Inc. - Deal signed for Glycomics Solution for proteomics research
Aichi Cancer Center - Intestinal metaplasia examined, endocrine cell co-existence described
American Academy of Dermatology - Boost vitamin D intake via nutrition, not sun, group says
American Academy of Dermatology - Group provides advice on avoiding skin cancer
American Academy of Dermatology - Skin cancer treatments focus on surgical approaches, new noninvasive therapies
AmpliMed - Amplimexon exhibits unique mechanisms of synergy with gemcitabine
Antisense Pharma GmbH - Patient recruitment completed for AP 12009 phase II trial
Antoni Van Leeuwenhoek Hospital, Amsterdam - Four different assays for the determination of serum S-100B compared
Ariad Pharmaceuticals, Inc. - IND filed with U.S. FDA to initiate trials of oral dosage form of AP23573
Asahikawa Medical College - Recent findings illuminate research in oncology
BioVisioN AG - ImVisioN sold to Nextech Venture, L.P.
Biomarker Technologies LLC - Makers of new blood test for breast cancer seeks future test candidates
Boston Medical Center - Nonsteroidal anti-inflammatory drugs for colorectal cancer prevention advised
Buck Institute for Age Research, Novato - NF kappa B activation identifies high-risk subset of ER-dependent cancers
Celera Genomics - Genomics company files IND application for HDAC inhibitor, CRA-024781
Central Brain Tumor Registry, Hinsdale - Consensus Conference discussed cancer registration of brain and CNS tumors
Centre Hospitalier Universitaire, Nancy - Cost-effectiveness of FDG-PET in lung cancer diagnostics analyzed
Chiang Mai University - P-glycoprotein function and expression inhibited by kaempferol and quercetin
Chiba National Cancer Center - Hyaluronan synthase expression marked pleural malignant mesotheliomas
Chiba University Hospital - Hormonal traits predict how well prostate cancer will respond to therapy
Chinese Academy of Sciences, Shanghai - Shiraia bambusicola derivative is a potent angiogenesis inhibitor
Chinese Academy of Sciences, Shanghai - Dual gene-virotherapy eradicates established tumors in animal models
Chinese People's Liberation Army General Hospital - Benign hyperplasia in the prostatic outer gland confused with prostate cancer
Chinese University of Hong Kong - Promoter hypermethylation of RASSF1A and MGMT linked with clinical implications
Chungtai Institute of Health Science, Taichung - Increased levels of urokinase plasminogen activator implicated in lung cancer
Colorado State University, Fort Collins - Refeeding after chronic dietary energy restriction reverses anticancer effect
Correlogic Systems, Inc. - Development of prostate cancer blood tests to move forward
Cutting Edge Information - Report shows pharma companies spend $76.8 million launching cancer treatments
Deutsch Krebsforschungszentrum, Heidelberg - Reports describe recent advances in leukemia research
DiagnoCure, Inc. - Cancer detection-focused company appoints CFO
Dresden University of Technology - HLA-DRB1* 01 genotype increases risk for adrenocortical carcinoma
Early Breast Cancer Trialists' Collaborative Group - Substantial 15-year survival gains from standard treatments
Emory University Hospital, Atlanta - LANA sensitive/specific KS marker in general and HIV-infected populations
Emory University, Atlanta - Interferon alfa-2a, isotretinoin, and vitamin E involved in phase 2 study
Endocyte, Inc. - Cancer/autoimmune-focused company moves operations to Purdue Technology Center
Evangelico Valdese Hospital, Turin - Fine-needle aspiration should be first step in assessing suspicious lymph nodes
G. Gaslini Children's Hospital, Genoa - Central venous catheter-related complications characterized
German Cancer Research Center DKFZ, Heidelberg - ERBB2 variant Ile654Val associated with increased familial breast cancer risk
Grant Life Sciences - Clinical trials of blood test for HPV-associated cervical cancer are underway
Harvard University - Local enucleation relieved symptoms in patients with esophageal leiomyoma
Harvard University - Researchers consider possible mechanistic links between obesity and asthma
Hokkaido University - Aberrant HOX gene expression related to breast cancer development
Hospital Calmette, Lille - RT-PCR is an early predictive factor of relapse risk in AML with t(8; 21)
Hospital La Fe, Valencia - Anterior chamber infiltrated in patient with Ph+ acute lymphoblastic leukemia
Hospital for Special Surgery, New York - How normal B cells become leukemic cells
IMI International Medical Innovations - Pivotal breast cancer study launched
INSERM U540 - Aromatase expression detected in some ovarian epithelial cancer cells, tissues
Indiana University - Esophageal cancer patients treated with neoadjuvant chemoradiation reviewed
Indiana University - Telomere dysfunction involved in aging and cancer
Information Technology - Impac to offer specimen tracking using barcoding technology
Institut Curie, Paris - One-thousandth patient treated with BEBIG seeds
Institute Gustave Roussy, Villejuif - Surgical treatment of peritoneal carcinomatosis examined
Institute of Cancer Research, London - Chemotherapy augments gene therapy targeting tumor vessels
Institute of Oncology, Ljubljana - Findings advance knowledge in breast cancer research
Int'l Center for Genetics Eng & Bio., Trieste - New findings in the area of cancer vaccines detailed
Kanazawa University - COX-2 inhibitor prevents esophageal inflammation-metaplasia-adenocarcinoma
Kanazawa University - Hematopoietic cells regulate angiogenic switch during tumorigenesis
Kangbuk Samsung Hospital - OcculTech fecal occult blood test suitable for colorectal neoplasia screening
Karolinska Hospital, Stockholm - Distribution of cutaneous squamous cell carcinoma in organ transplant recipients
Karolinska Institute - Tobacco smoking and snuff dipping implicated in risk of squamous cell carcinoma
Karolinska University Hospital, Stockholm - Cyclin B1 predicts favorable outcomes in patients with follicular lymphoma
Keio University, Tokyo - Microsatellite instability in inflamed mucosa helped predict colonic neoplasms
Kyoto University - Cisplatin/adriamycin release from hydrogel has synergistic antitumor effects
Kyung Hee University Hospital, Seoul - Factors raise cancer risk in those with current and past HBV infections
Leiden University - Cancer immunotherapy targets minor histocompatibility antigens
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.